QuidelOrtho Corporation - Common Stock - Nakit Akışı (NASDAQ:QDEL)

Financials

İşletme faaliyetlerinden elde edilen nakit 885.3 M280.2 M83 M105.2 M 6.6 M Yatırım faaliyetlerinden elde edilen nakit -1.64 B-187.6 M-149.9 M-192.7 M -170.5 M Finansman faaliyetlerinden elde edilen nakit 252 M-265.8 M48.8 M155.8 M 175.8 M Serbest nakit akışı 885.3 M280.2 M83 M-83 M -159.4 M

QuidelOrtho Corporation - Common Stock

QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

QDEL

Financials

QuidelOrtho Corporation - Common Stock

Haberler

QuidelOrtho: A Growing, Stable Business With A Significant Mispricing (NASDAQ:QDEL)

McIntyre Partnerships Q1 2026 Partners Letter

Jefferies, kazanç görünürlüğü endişeleriyle Quidel hissesini düşürdü

QDEL Stock Down as Q1 Earnings Miss Estimates, Revenues Down Y/Y

QuidelOrtho Corporation (QDEL) Q1 2026 Earnings Call Transcript

QuidelOrtho 1Ç 2026: Gelir %13 düştü, solunum zayıflığı baskı yaptı

QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates

Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for

Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline

QuidelOrtho moleküler teşhis firması LEX Diagnostics’i satın aldı

QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes (NASDAQ:QDEL)

Stocks Settle Higher on Tech Earnings and Ceasefire Optimism